Post Publication Amendment

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1771 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

---

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number. PTO Form 1771 (Rev 10/2011)

OMB No. 0651-0050 (Exp 09/20/2020)

Post-Approval/Publication/Post-Notice of Allowance (NOA) Amendment

To the Commissioner for Trademarks:

Application serial no. 88352451 DOJOLVI(Standard Characters, see http://uspto.report/TM/88352451/mark.png) has been amended as follows:

EXPLANATION OF FILING
Applicant has noted a minor typo in its description of goods, namely, that "long-chain fatty acid oxidation disorders (LC-FOAD)" should instead be corrected to read "long-chain fatty acid oxidation disorders (LC-FAOD)." Applicant respectfully submits that this minor correction to the acronym does not require republication.

CLASSIFICATION AND LISTING OF GOODS/SERVICES

Applicant proposes to amend the following class of goods/services in the application:
Current: Class 005 for pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FOAD)
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

Proposed:
Tracked Text Description: pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FOAD); pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)Class 005 for pharmaceuticals for use in treating genetic disorders, autosomal disorders, lysosomal storage disorders, metabolic disorders, energy deficiency disorders, and enzyme disorders; pharmaceuticals for use in treating long-chain fatty acid oxidation disorders (LC-FAOD)
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to use the mark in commerce on or in connection with the identified goods/services in the application. For a collective trademark, collective service mark, or collective membership mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members on or in connection with the identified goods/services/collective membership organization. For a certification mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that meet the certification standards of the applicant.

The applicant's current attorney information: Anne H. Peck. Anne H. Peck of COOLEY LLP, is located at

      1299 PENNSYLVANIA AVENUE NW, SUITE 700
      WASHINGTON, District of Columbia 20004
      US
The docket/reference number is 315613-20000.

The email address is trademarks@cooley.com

The applicants proposed attorney information: Anne H. Peck. Other appointed attorneys are Jeffrey Greene, Salsa Ahmed, Colette Ghazarian, Rose Kautz, Susan Piascik Christoff, John W. Crittenden, Bobby A. Ghajar, Rebecca Givner-Forbes, Brian Focarino, Shannan Higgins, Ariana Gallisa Hiscott, Brendan J. Hughes, Judd D. Lauter, Lori A. Levine, John Paul Oleksiuk, Marcus D. Peterson, Kathlyn Querubin, Elisa Rosen, Shane Rumbaugh, Jan van Benten, Dina Roumiantseva, Colleen Wellington-Caban, and Karen K. Won. Anne H. Peck of Cooley LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at

      1299 Pennsylvania Avenue, N.W.
      Suite 700
      Washington, District of Columbia 20004
      United States
The docket/reference number is 315613-20000.

The email address is trademarks@cooley.com

Anne H. Peck submitted the following statement: I attest that I am an attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory).
The applicant's current correspondence information: ANNE H. PECK. ANNE H. PECK of COOLEY LLP, is located at

      1299 PENNSYLVANIA AVENUE NW, SUITE 700
      WASHINGTON, District of Columbia 20004
      US
The docket/reference number is 315613-20000.

The email address is trademarks@cooley.com

The applicants proposed correspondence information: Anne H. Peck. Anne H. Peck of Cooley LLP, is located at

      1299 Pennsylvania Avenue, N.W.
      Suite 700
      Washington, District of Columbia 20004
      United States
The docket/reference number is 315613-20000.

The email address is trademarks@cooley.com; bfocarino@cooley.com; myoung@cooley.com

SIGNATURE(S)

Signature: /Brian J. Focarino/     Date: 08/14/2019
Signatory's Name: Brian J. Focarino
Signatory's Position: Attorney of Record, California Bar Member

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    ANNE H. PECK
   COOLEY LLP
   
   1299 PENNSYLVANIA AVENUE NW, SUITE 700
   WASHINGTON, District of Columbia 20004
Mailing Address:    Anne H. Peck
   Cooley LLP
   1299 Pennsylvania Avenue, N.W.
   Suite 700
   Washington, District of Columbia 20004
        
Serial Number: 88352451
Internet Transmission Date: Wed Aug 14 09:12:57 EDT 2019
TEAS Stamp: USPTO/PPA-XXX.XXX.XXX.XX-201908140912577
54278-88352451-610ef37571eaedb963fd991c8
a94fd2dcd9fe39b8c92fc27c16260420aaab22-N
/A-N/A-20190814085732717360